학술논문
Preliminary Results from a Phase I Study of HMPL-523, a Selective Oral Syk Inhibitor, in Patients with Relapsed or Refractory Lymphoma
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020